Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sunitinib Either Before or After Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma

NCT00626509 is registered in ClinicalTrials.gov with Gruppo Italiano Carcinoma Renale as lead sponsor.

NCT NCT00626509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00626509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sunitinib Either Before or After Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma
Lead sponsor
Gruppo Italiano Carcinoma Renale
Phase
Phase 2
Overall status
Unknown status
Start date
February 29, 2008
Completion date
Not reported
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer